期刊文献+

加味木防己汤抗大鼠实验性关节炎的研究 被引量:7

Experimental Study on Anti-arthritis Effect of Jiawei Mufangji Decoction in Rats
下载PDF
导出
摘要 目的探讨加味木防己汤对大鼠实验性佐剂关节炎(adjuvantarthritis,AA)的作用及其机制。方法应用弗氏完全佐剂注射诱发大鼠产生实验性关节炎,第18天开始给予加味木防己汤灌胃,39天测量AA大鼠体重,脾及胸腺指数,足肿胀度。HE染色观察大鼠踝关节组织病理学变化,ELISA法测定大鼠血清中白细胞介素-1β(IL-1β),肿瘤坏死因子-α(TNF-α)的含量。结果加味木防己汤能缓解AA病情,使足肿胀度下降,体重及脏器指数改善,关节水肿减轻,淋巴细胞浸润明显减少,滑膜增生受抑制。血清IL-1β,TNF-α的含量明显下降。结论加味木防己汤对AA大鼠的治疗作用,可能与其下调IL-1β,TNF-α的含量有关。 Objective To explore the therapeutic effect of Jiawu Mufangji Decoction (JMD) in treating rats with adjuvant arthritis (AA) and its mechanism. Methods AA model rats induced by Freund's complete adjuvant were treated with JMD by gastrogavage starting from 18 days after modeling. On the 39th day, body weight, spleen and thymus index, and swelling degree of paw of the AA rats were measured, pathological changes of the ankle joint tissue were observed using HE staining, and serum levels of interleukin-1β (IL-1β) and tumor necrosis factor α (TNF-α) were determined by enzyme-linked immunosorbent assay (ELISA). Results JMI) could relieve the symptoms of AA rats, decrease the paw swelling, improve the weight and spleen and thymus index, reduce the dropsy of joints and lymphocytes infiltration, inhibit the proliferation of synoviurn, and obviously lower the serum levels of interleukin-1β and TNF-α. Conclusion The therapeutic effect of JMD might be related to its action in down-regulating the serum levels of IL-1β and tumor necrosis factor α.
出处 《中国中西医结合杂志》 CAS CSCD 北大核心 2005年第8期727-729,共3页 Chinese Journal of Integrated Traditional and Western Medicine
基金 国家中医药管理局科研基金资助项目(No.04-05JP01)
  • 相关文献

参考文献8

  • 1Jacobson PB, Borgan SJ, Wilcox DM, et al. A new spin on an old model: In vivo evaluation of disease progression by magnetic resonance imaging with respect to standard inflammatory parameters and histopathology in the adjuvant arthritic rat. Arthr Rheum 1999 ;42(10) :2060-2073.
  • 2马东来,李俊.大鼠佐剂性关节炎的诱导及其免疫异常研究[J].中国实验临床免疫学杂志,1995,7(3):13-17. 被引量:60
  • 3林红,贺永怀,黎燕,陆应麟,沈倍奋.Ⅱ型胶原蛋白与弗氏完全佐剂大鼠关节炎模型的建立和比较[J].中国实验动物学报,1999,7(1):1-6. 被引量:54
  • 4Gravallese EM, Goldring SR. Cellular mechanism and the role of cytokines in bone erosions in rheumatoid arthritis. Arthr Rheum 2000; 43 (10): 2143-2151.
  • 5Isomaki P, Luukkainen R, Toivanen P, et al. The presence of interleukin-1β in rheumatoid synovium and anti-inflammatory effects on synovial fluid macrophages from patients with rheumatoid arthritis. Arthr Rheum 1996; 39 ( 10 ): 1693-1702.
  • 6Camussi G, Lapia E. The future role of anti-tumor necrosis factor (TNF) products in the treatment of rheumatoid arthritis. Drugs 1998;55:613-620.
  • 7Molving J. Endotoxin-stimulated human monocyte secretion of interleukin-1, tumor necrosis factor alpha, and prostaglandin E2 shows stable interindividual differences. Scand J Immunol 1998;27(6) :705.
  • 8Atend WP, Dayer JM. Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis. Arthr Rheum 1990;33:305.

共引文献111

同被引文献99

引证文献7

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部